Brand
Scynexis, Inc.
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Scynexis, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2023-10-18FDA-DrugClass IBREXAFEMME (Ibrexafungerp) tablets 150 mg, 4 count cartons, Rx Only, Manufactured for and distributed by SCYNEXIS, Inc., Jersey City, NJ 07302 NDC 75788-115-04
Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
Get notified about new Scynexis, Inc. recalls
Free weekly digest. We email when a new federal recall affects Scynexis, Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state